From: <Saved by Windows Internet Explorer 7>
Subject: LACTOFERRINE - Fascinerende bondgenoot in de verdediging tegen endogene en exogene belagers
Date: Mon, 9 Oct 2006 10:20:32 +0200
MIME-Version: 1.0
Content-Type: multipart/related;
	type="multipart/alternative";
	boundary="----=_NextPart_000_0000_01C6EB8C.8D0B88D0"
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.2962

This is a multi-part message in MIME format.

------=_NextPart_000_0000_01C6EB8C.8D0B88D0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: file:///D:/Alternatieve%20geneeskunde%202005/Alternatieve%20geneeskunde/Amino's/LACTOFERRINE%20-%20Fascinerende%20bondgenoot%20in%20de%20verdediging%20tegen%20endogene%20en%20exogene%20belagers_bestanden/logo.gif
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=

------=_NextPart_000_0000_01C6EB8C.8D0B88D0
Content-Type: application/octet-stream
Content-Transfer-Encoding: base64
Content-Location: file:///D:/Alternatieve%20geneeskunde%202005/Alternatieve%20geneeskunde/Amino's/LACTOFERRINE%20-%20Fascinerende%20bondgenoot%20in%20de%20verdediging%20tegen%20endogene%20en%20exogene%20belagers_bestanden/zwanger.jpg
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------=_NextPart_000_0000_01C6EB8C.8D0B88D0
Content-Type: application/octet-stream
Content-Transfer-Encoding: base64
Content-Location: file:///D:/Alternatieve%20geneeskunde%202005/Alternatieve%20geneeskunde/Amino's/LACTOFERRINE%20-%20Fascinerende%20bondgenoot%20in%20de%20verdediging%20tegen%20endogene%20en%20exogene%20belagers_bestanden/lactoferrine.jpg
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------=_NextPart_000_0000_01C6EB8C.8D0B88D0
Content-Type: application/octet-stream
Content-Transfer-Encoding: base64
Content-Location: file:///D:/Alternatieve%20geneeskunde%202005/Alternatieve%20geneeskunde/Amino's/LACTOFERRINE%20-%20Fascinerende%20bondgenoot%20in%20de%20verdediging%20tegen%20endogene%20en%20exogene%20belagers_bestanden/koeien.jpg
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------=_NextPart_000_0000_01C6EB8C.8D0B88D0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: file:///D:/Alternatieve%20geneeskunde%202005/Alternatieve%20geneeskunde/Amino's/LACTOFERRINE - Fascinerende bondgenoot in de verdediging tegen endogene en exogene belagers_bestanden/back.gif
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------=_NextPart_000_0000_01C6EB8C.8D0B88D0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_000B_01C6EB8C.8D0DF9D0"


------=_NextPart_001_000B_01C6EB8C.8D0DF9D0
Content-Type: text/html;
	charset="Windows-1252"
Content-Transfer-Encoding: quoted-printable
Content-Location: file://D:\Alternatieve geneeskunde 2005\Alternatieve geneeskunde\Amino's\LACTOFERRINE - Fascinerende bondgenoot in de verdediging tegen endogene en exogene belagers.htm

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from =
url=3D(0053)http://www.orthos.nl/media/perio/DOK105/DOK105art.htm =
--><HTML><HEAD><TITLE>LACTOFERRINE - Fascinerende bondgenoot in de =
verdediging tegen endogene en exogene belagers</TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dwindows-1252"><!--
      =20
       Webdesign
       Bureau Everink
       Almere
       www.bureve.com
              =20
       -->
<META=20
content=3D"Artikel door D=E9sir=E9e L. R=F6ver. Lactoferrine is een =
bioactieve glycoprote=EFne die via uiteenlopende processen het lichaam =
beschermt tegen endogene en exogene belagers. Dankzij moderne =
filtertechnieken kan dit veelzijdige peptide nu als voedingssupplement =
worden ingezet."=20
name=3Ddescription>
<META=20
content=3D"orthos media, r=F6ver, orthomoleculaire koerier, =
orthomoleculair, orthomoleculaire geneeskunde, voedingsleer, =
lactoferrine, glycoprote=EFne, anti-oxidant, antioxidant, cytokinen, =
voedingssupplement, afweer, afweersysteem, immuniteit, probioticum, =
antibiotica"=20
name=3Dkeywords>
<META content=3D"Orthos Media bv, Den Haag, Netherlands" name=3DAuthor>
<META content=3D"Orthos Media bv, Den Haag, Netherlands" =
name=3DCopyright>
<META content=3D"MSHTML 6.00.5700.6" name=3DGENERATOR>
<META content=3DFrontPage.Editor.Document name=3DProgId>
<STYLE>.body-tekst {
	FONT-SIZE: 16px; FONT-FAMILY: Century Gothic, Arial, Verdana
}
.referenties {
	FONT-SIZE: 17px; FONT-FAMILY: Times New Roman
}
.kopje {
	FONT-SIZE: 20px; FONT-FAMILY: Calisto MT, Times New Roman
}
</STYLE>
<LINK=20
href=3D"LACTOFERRINE - Fascinerende bondgenoot in de verdediging tegen =
endogene en exogene belagers_bestanden/opmaak_DOK.css"=20
type=3Dtext/css rel=3Dstylesheet></HEAD>
<BODY leftMargin=3D0=20
background=3D"file:///D:/Alternatieve%20geneeskunde%202005/Alternatieve%2=
0geneeskunde/Amino's/LACTOFERRINE - Fascinerende bondgenoot in de =
verdediging tegen endogene en exogene belagers_bestanden/back.gif"=20
topMargin=3D0 rightMargin=3D0>
<DIV align=3Dcenter>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"98%" border=3D0>
  <TBODY>
  <TR>
    <TD width=3D"50%"><IMG height=3D61=20
      =
src=3D"file:///D:/Alternatieve%20geneeskunde%202005/Alternatieve%20genees=
kunde/Amino's/LACTOFERRINE%20-%20Fascinerende%20bondgenoot%20in%20de%20ve=
rdediging%20tegen%20endogene%20en%20exogene%20belagers_bestanden/logo.gif=
"=20
      width=3D323></TD>
    <TD align=3Dmiddle width=3D"50%">
      <DIV align=3Dcenter>
      <CENTER>
      <TABLE cellSpacing=3D3 cellPadding=3D2 width=3D"100%" border=3D0>
        <TBODY>
        <TR>
          <TD align=3Dmiddle width=3D"25%" bgColor=3D#fbe3c1><A=20
            href=3D"http://www.orthos.nl/media/elek.htm" =
target=3D_top><FONT=20
            size=3D2>Elektr.<BR>media</FONT></A></TD>
          <TD align=3Dmiddle width=3D"25%" bgColor=3D#fbe3c1><A=20
            href=3D"http://www.orthos.nl/media/perio.htm" =
target=3D_top><FONT=20
            size=3D2>Perio-<BR>dieken</FONT></A></TD>
          <TD align=3Dmiddle width=3D"25%" bgColor=3D#fbe3c1><A=20
            href=3D"http://www.orthos.nl/media/boeken.htm" =
target=3D_top><FONT=20
            size=3D2>Boeken</FONT></A></TD>
          <TD align=3Dmiddle width=3D"25%" bgColor=3D#fbe3c1><A=20
            href=3D"http://www.orthos.nl/media/index.htm" =
target=3D_top><FONT=20
            =
size=3D2>HOME</FONT></A></TD></TR></TBODY></TABLE></CENTER></DIV></TD></T=
R></TBODY></TABLE></CENTER></DIV>
<DIV align=3Dcenter>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D6 width=3D"98%" border=3D0>
  <TBODY>
  <TR>
    <TD align=3Dmiddle width=3D"100%"><IFRAME name=3DI1 marginWidth=3D0 =
marginHeight=3D0=20
      src=3D"file://D:\Alternatieve geneeskunde 2005\Alternatieve =
geneeskunde\Amino's\LACTOFERRINE - Fascinerende bondgenoot in de =
verdediging tegen endogene en exogene =
belagers_bestanden\adresregel-insert.htm"=20
      frameBorder=3D0 width=3D555 scrolling=3Dno=20
height=3D14>
</IFRAME></TD></TR></TBODY></TABLE></CENTER></DIV>
<DIV align=3Dcenter>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"98%" bgColor=3D#f2a228 =
border=3D0>
  <TBODY>
  <TR>
    <TD align=3Dmiddle width=3D"100%"><IMG height=3D1 src=3D""=20
width=3D10></TD></TR></TBODY></TABLE></CENTER></DIV>
<DIV align=3Dcenter>
<BLOCKQUOTE>
  <DIV align=3Dcenter>&nbsp;</DIV><FONT face=3DArial>
  <DIV align=3Dleft>
  <TABLE cellSpacing=3D0 cellPadding=3D10 width=3D"85%" =
bgColor=3D#fbe3c1 border=3D0>
    <TBODY>
    <TR>
      <TD width=3D"60%">Deze pagina is onderdeel van een reeks online =
artikelen=20
        die oorspronkelijk zijn verschenen in het vaktijdschrift De=20
        Orthomoleculaire Koerier. </TD>
      <TD align=3Dmiddle width=3D"40%">
        <DIV align=3Dright>
        <TABLE cellSpacing=3D0 cellPadding=3D5 width=3D200 =
bgColor=3D#f5f5f5 border=3D0>
          <TBODY>
          <TR>
            <TD align=3Dmiddle width=3D"100%"><A=20
              href=3D"http://www.orthos.nl/media/perio/DOKind.htm"=20
              target=3D_top><FONT face=3DVerdana size=3D3>Naar de index =
van de online=20
              selectie uit De Orthomoleculaire=20
        =
Koerier.</FONT></A></TD></TR></TBODY></TABLE></DIV></TD></TR></TBODY></TA=
BLE></DIV></FONT>
  <H1 align=3Dleft><SPAN style=3D"FONT-WEIGHT: 400"><B><FONT =
face=3DVerdana=20
  color=3D#15c00c size=3D4><BR></FONT></B><FONT face=3DVerdana =
size=3D4>LACTOFERRINE *=20
  LACTOFERRINE * LACTOFERRINE * LACTOFERRINE * =
LACTOFERRINE</FONT></SPAN></H1>
  <H1 align=3Dleft><FONT color=3D#15c00c>Fascinerende bondgenoot in de =
verdediging=20
  tegen endogene en exogene belagers</FONT></H1>
  <BLOCKQUOTE>
    <P align=3Dleft><FONT face=3D"Lucida Sans Unicode">D=E9sir=E9e L.=20
    R=F6ver,<BR></FONT><FONT face=3D"Century Gothic">medisch=20
  journaliste</FONT></P></BLOCKQUOTE>
  <P class=3Dinleiding align=3Dleft>Lactoferrine is een bioactieve =
glycoprote=EFne die=20
  via uiteenlopende processen het lichaam beschermt tegen endogene en =
exogene=20
  belagers. Zo moduleert, co=F6rdineert en reguleert dit lichaamseigen =
melkeiwit=20
  de cellulaire respons en belemmert het via een unieke ijzerhuishouding =
een=20
  breed scala aan ziektekiemen en tumoren in hun groei en reproductie. =
Verder=20
  profileert de stof zich als een krachtige anti-oxidant en creatief =
regisseur=20
  van cytokinen.<BR>Dankzij moderne filtertechnieken kan dit veelzijdige =
peptide=20
  nu als voedingssupplement worden ingezet ter verhoging van de =
immuniteit, als=20
  probioticum, als adjuvans bij kankertherapie en ook daar waar =
conventionele=20
  antibiotica geen resultaten (meer) opleveren.</P></BLOCKQUOTE>
<DIV align=3Dleft>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"94%" border=3D0>
  <TBODY>
  <TR>
    <TD>
      <BLOCKQUOTE>
        <P class=3Dkopje align=3Dleft><BR>Veelzijdig, samenwerkend</P>
        <P class=3Dbody-tekst align=3Dleft>Lactoferrine is een uit =
=E9=E9n enkele reeks=20
        aminozuren opgebouwd glucoprote=EFnemolecuul dat bijzonder =
bestand is=20
        tegen afbraak, een eigenschap die deze stof na orale inname een=20
        profijtelijk langdurige activiteit meegeeft. De ijzergebonden =
vorm van=20
        lactoferrine heet hololactoferrine, de ijzervrije vorm wordt=20
        apolactoferrine genoemd. Het eiwit werd zo'n 35 jaar geleden =
ontdekt en=20
        blijkt veel verschillende kwaliteiten te hebben. De naam =
lactoferrine=20
        verwijst zowel naar de herkomst, als naar (slechts) een van de =
meest=20
        opmerkelijke eigenschappen ervan: het interactief vermogen om =
ijzer aan=20
        zich te binden, daar waar nodig naartoe te transporteren, of =
juist te=20
        onttrekken.</P>
        <P class=3Dbody-tekst align=3Dleft>Het voornaamste =
ijzertransporterende=20
        eiwit in het lichaam is transferrine, een b=E8ta-globuline met =
twee=20
        bindingsplaatsen voor ijzer, dat via de rode bloedlichaampjes =
ijzer de=20
        cel in brengt. In die kwaliteit is lactoferrine echter =
honderdmaal=20
        krachtiger en eist daarmee moeiteloos de hoofdrol op in de =
immuunrespons=20
        van het lichaam - de stof vormt de frontlinie bij de verdediging =
tegen=20
        zowel in-, als externe ziekteverwekkende =
invloeden.</P></BLOCKQUOTE></TD>
    <TD vAlign=3Dtop align=3Dright width=3D150><FONT face=3DArial =
size=3D2><STRONG=20
      style=3D"FONT-WEIGHT: 400"><B><BR><BR><BR><BR><BR><BR><BR>Al =
tijdens=20
      de<BR>zwangerschap <BR>speelt lactoferrine<BR>een essenti=EBle=20
      rol<BR>aangezien deze stof<BR>het immuunsysteem<BR>van de=20
      moeder<BR>verhindert te<BR>reageren op de<BR>vreemde =
eiwitten<BR>van de=20
      vader<BR>die door de foetus<BR>&nbsp;worden =
afgegeven.<BR></B>Foto: Chris=20
      M=FCller<BR>&nbsp;Photodesign</STRONG></FONT> </TD>
    <TD vAlign=3Dtop>
      <P align=3Dcenter><BR><BR><BR><IMG height=3D421 hspace=3D15=20
      =
src=3D"file:///D:/Alternatieve%20geneeskunde%202005/Alternatieve%20genees=
kunde/Amino's/LACTOFERRINE%20-%20Fascinerende%20bondgenoot%20in%20de%20ve=
rdediging%20tegen%20endogene%20en%20exogene%20belagers_bestanden/zwanger.=
jpg"=20
      width=3D180 =
border=3D0><BR>&nbsp;</P></TD></TR></TBODY></TABLE></DIV>
<BLOCKQUOTE><FONT face=3DArial></FONT>
  <P class=3Dbody-tekst align=3Dleft>Niet voor niets komen de hoogste =
concentraties=20
  van lactoferrine voor in colostrum, de eerste melkafgifte van =
zoogdieren en=20
  mensen. Het menselijk colostrum bevat 7 g lactoferrine per liter, =
latere=20
  borstvoeding doorgaans 1 g/l; bij koemelk liggen beide percentages =
lager.</P>
  <P class=3Dbody-tekst align=3Dleft>Lysozym is een bacteriolytisch =
werkend enzym=20
  dat in 1922 door Fleming werd ge=EFdentificeerd in neusvocht. =
Naderhand werd dit=20
  lysosomaal enzym in bijna alle levende weefsels gevonden. Lysozym is =
enerzijds=20
  in staat de celwand van bacteri=EBn te beschadigen en helpt anderzijds =
de=20
  (antibacteri=EBle) eigenschappen van lactoferrine te verhogen. =
Lactoferrine, in=20
  tandem met lysozym, helpt de baby na de geboorte niet alleen in de =
bescherming=20
  tegen virale en bacteri=EBle infecties, maar ook bij het ontwikkelen =
van een=20
  gezond en goed functionerend immuunsysteem. Het zeer breed gerichte=20
  takenpakket dat lactoferrine tijdens de lactatieperiode vervult, is =
=E9=E9n van de=20
  vele redenen waarom borstvoeding voor het algeheel welbevinden van =
baby's zo=20
  van cruciaal belang is, niet alleen voor de korte, maar juist ook voor =
de=20
  lange termijn. Bijzonder is verder dat lactoferrine ook al tijdens de=20
  zwangerschap een essenti=EBle rol speelt: dan verhindert deze stof het =

  immuunsysteem van de moeder te reageren op de vreemde eiwitten van de =
vader=20
  die door de foetus worden afgegeven.</P>
  <P class=3Dkopje align=3Dleft><BR>Wei</P>
  <P class=3Dbody-tekst align=3Dleft>Behalve in moedermelk komt =
lactoferrine in het=20
  menselijk lichaam zoals gezegd ook op verschillende andere plaatsen =
voor: in=20
  neutrofiele granulocyten (fagocyten, witte bloedcellen) en in =
cellulaire=20
  afscheidingen, zoals traanvocht, speeksel en sperma. Verder in het =
slijm van=20
  vagina, bronchi=EBn en neus, in gal, en in de vloeistoffen van de =
alvleesklier.=20
  Bovendien wordt lactoferrine geproduceerd in polymorfonucleaire =
leukocyten die=20
  deze stof vervolgens naar de septische plaatsen brengen.</P>
  <P class=3Dbody-tekst align=3Dleft>Terwijl menselijke moedermelk tot =
15%=20
  lactoferrine kan bevatten, ligt het gehalte daarvan in de wei van =
koemelk=20
  tussen de 0,5% en 1%.</P></BLOCKQUOTE>
<DIV align=3Dleft>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%" border=3D0>
  <TBODY>
  <TR>
    <TD>
      <BLOCKQUOTE>
        <P class=3Dbody-tekst align=3Dleft>Koemelk bevat twee =
belangrijke prote=EFnen:=20
        case=EFne en wei. </P>
        <P class=3Dbody-tekst align=3Dleft><B><FONT =
color=3D#ff0000>Case=EFne</FONT></B>=20
        - dit voornaamste melkeiwit is een fosfoprote=EFne, gericht op =
de snelle=20
        groei van het kalf. De stof kenmerkt zich door een zeer grote =
plakkracht=20
        die bij het drinken van koemelk in de menselijke organen =
verklevingen=20
        kan veroorzaken. In de bronchi=EBn leiden deze tot deze =
astma-achtige=20
        aanvallen die, zoals in het geval van de kleurrijke Amerikaanse =
atlete=20
        Flo Jo Griffith, de dood tot gevolg kunnen =
hebben.</P></BLOCKQUOTE></TD>
    <TD width=3D400>
      <DIV align=3Dcenter>
      <TABLE cellPadding=3D10 width=3D300 bgColor=3D#f4d7f3 border=3D0>
        <TBODY>
        <TR>
          <TD>
            <P align=3Dcenter><B><FONT face=3D"Times New Roman" =
size=3D3>Een studie=20
            vergeleek 30 gezonde controlepersonen met 22 HIV-pati=EBnten =
zonder en=20
            45 HIV-pati=EBnten met symptomen, en vond dat de niveaus van =

            lactoferrine in het plasma bij pati=EBnten ge=EFnfecteerd =
met HIV-1=20
            lager zijn naarmate de ziekte verder is=20
        =
gevorderd.</FONT></B></P></TD></TR></TBODY></TABLE></DIV></TD></TR></TBOD=
Y></TABLE></DIV>
<BLOCKQUOTE>
  <P class=3Dbody-tekst align=3Dleft><FONT =
color=3D#ff0000><B>Wei</B></FONT>=20
  daarentegen blijkt over vele leven gevende eigenschappen te =
beschikken. Het is=20
  een complex eiwit dat uit verschillende kleinere subfracties =
(peptiden)=20
  bestaat: b=E8ta-lactoglobuline, alfa-lactabumine, immunoglobolines =
(IgGs),=20
  glycomacropeptiden, bovine serum albumine (BSA) en kleinere peptiden, =
zoals=20
  lactoperoxidase, lysozym en lactoferrine. Ieder van deze subfracties =
kenmerkt=20
  zich door geheel eigen, unieke biologische eigenschappen.</P>
  <P class=3Dbody-tekst align=3Dleft>De filtertechnieken, nodig om deze =
subfracties=20
  van elkaar te scheiden, zijn recentelijk ontwikkeld in Nieuw-Zeeland =
en... in=20
  Nederland!</P>
  <P class=3Dkopje align=3Dleft><BR>Verschillende functionele =
processen</P>
  <P class=3Dbody-tekst align=3Dleft>Een goed inzicht over de =
eigenschappen van een=20
  bepaalde stof wordt doorgaans geboden door de locatie van de =
receptoren waarop=20
  deze stof zich bindt. Voor lactoferrine zijn er receptoren gevonden in =
de=20
  darmen, in de hersenen, op verschillende witte bloedcellen, op =
bloedplaatjes=20
  en op bepaalde bacteri=EBn. Een artikel in 'Nature' beschrijft hoe =
lactoferrine=20
  zich kan binden met delen van het DNA in de celkern en zo direct de =
activiteit=20
  kan be=EFnvloeden van de genen die coderen voor de eiwitten van de =
cel. Gezien=20
  de diversiteit van receptoren waarop lactoferrine bindt, is het dan =
ook niet=20
  vreemd dat de positieve effecten van deze stof worden verkregen vanuit =

  verschillende afzonderlijke functionele processen:</P>
  <UL>
    <LI>
    <P class=3Dbody-tekst align=3Dleft>ribonuclease-activiteit: het =
vermogen om=20
    binnen nucle=EFnezuurmoleculen verbindingen te verbreken, onder meer =
in=20
    RNA;</P>
    <LI>
    <P class=3Dbody-tekst align=3Dleft>het onthouden van ijzer aan =
pathogene=20
    bacteri=EBn en tumoren, waardoor deze in hun groei en reproductie =
worden=20
    belemmerd;</P>
    <LI>
    <P class=3Dbody-tekst align=3Dleft>bevordering van =
T-celdifferentiatie (synthese=20
    van T4, T8, T-cytotoxische, en NK-cellen (natural killer cells);</P>
    <LI>
    <P class=3Dbody-tekst align=3Dleft>activering van het humorale =
systeem=20
    (antistoffen-synthese);</P>
    <LI>
    <P class=3Dbody-tekst align=3Dleft>het doden van virussen en =
bacteri=EBn bij=20
    contact.</P></LI></UL></BLOCKQUOTE>
<TABLE style=3D"BORDER-COLLAPSE: collapse" borderColor=3D#840084 =
cellPadding=3D20=20
width=3D700 bgColor=3D#ffe8ff border=3D1>
  <TBODY>
  <TR>
    <TD>
      <P class=3Dkopje align=3Dleft><U><FONT face=3D"Times New Roman"=20
      size=3D5>Activiteiten van lactoferrine:</FONT></U></P>
      <UL>
        <LI>
        <P align=3Dleft><FONT face=3D"Times New Roman"><B>activeert DNA =
tot=20
        krachtige immuunrespons tegen bacteri=EBn, virussen en=20
        schimmels;</B></FONT></P>
        <LI>
        <P align=3Dleft><FONT face=3D"Times New Roman"><B>interfereert =
met het=20
        koolhydratenmetabolisme van binnenkomende =
organismen;</B></FONT></P>
        <LI>
        <P align=3Dleft><FONT face=3D"Times New Roman"><B>interfereert =
met het=20
        vermogen van binnenkomende organismen om RNA te synthetiseren, =
een=20
        proces dat zij voor hun prote=EFnesynthese nodig =
hebben;</B></FONT></P>
        <LI>
        <P align=3Dleft><FONT face=3D"Times New Roman"><B>werkt in =
synergie met=20
        lysozym om de activiteit van beide prote=EFnen op te=20
wekken;</B></FONT></P>
        <LI>
        <P align=3Dleft><FONT face=3D"Times New Roman"><B>cre=EBert =
natuurlijke=20
        antilichamen tegen een breed scala van =
ziektekiemen;</B></FONT></P>
        <LI>
        <P align=3Dleft><FONT face=3D"Times New Roman"><B>verbetert =
transport en=20
        opname van ijzer (grote bindkracht voor twee=20
        ijzermoleculen);</B></FONT></P>
        <LI>
        <P align=3Dleft><FONT face=3D"Times New Roman"><B>werkt samen =
met en=20
        bespaart glutamine;</B></FONT></P>
        <LI>
        <P align=3Dleft><FONT face=3D"Times New Roman"><B>brengt de =
darmflora in=20
        balans;</B></FONT></P>
        <LI>
        <P align=3Dleft><FONT face=3D"Times New Roman"><B>uiterst =
krachtige=20
        anti-oxidant: vangt vrije radicalen en voorkomt de vorming=20
        daarvan;</B></FONT></P>
        <LI>
        <P align=3Dleft><FONT face=3D"Times New Roman"><B>krachtig =
antikankereffect:=20
        blokkeert de bloedtoevoer naar de kankercel=20
(angiogenese);</B></FONT></P>
        <LI>
        <P align=3Dleft><FONT face=3D"Times New Roman"><B>ctiveert =
NK-cellen=20
        (natural killer =
cells).</B></FONT></P></LI></UL></TD></TR></TBODY></TABLE>
<BLOCKQUOTE>
  <P class=3Dkopje align=3Dleft><BR>Virale effecten</P>
  <P class=3Dbody-tekst align=3Dleft>In directe zin grijpt lactoferrine =
in tegen=20
  virussen door zich te binden aan virale receptorplaatsen, zodat het=20
  desbetreffende virus de gezonde cellen niet kan infecteren.=20
  Laboratoriumexperimenten bevestigen hoe zowel het menselijk =
cytomegalovirus=20
  (HCMV), het menselijk herpes simplex virus-1, als het menselijk=20
  immunodefici=EBntie virus (HIV) het in hun celvermeerdering moeten =
afleggen=20
  tegen lactoferrines krachtige antivirale effecten. Wat HIV betreft, =
heeft men=20
  kunnen constateren dat lactoferrine zich krachtig bindt aan de V3-lus =
van de=20
  gp120-receptor op HIV-1 en HIV-2, met als resultaat dat virus en cel =
niet=20
  kunnen samensmelten.</P>
  <P class=3Dbody-tekst align=3Dleft>Indirect doodt of belemmert =
lactoferrine=20
  virussen door bij een virale invasie de systemische immuunrespons te =
verhogen.=20
  Interessant is dat mensen met een HIV-infectie een systemische =
defici=EBntie van=20
  lactoferrine vertonen. Bij sommige aids-pati=EBnten kan een tekort aan =

  lactoferrine in het traanvocht het 'droge ogen syndroom' opleveren, =
een=20
  aandoening die wordt gekenmerkt door te weinig traanvocht en een =
degeneratie=20
  in het oogweefsel.</P>
  <P class=3Dbody-tekst align=3Dleft>Een studie vergeleek 30 gezonde=20
  controlepersonen met 22 HIV-pati=EBnten zonder en 45 HIV-pati=EBnten =
met=20
  symptomen, en vond dat de niveaus van lactoferrine in het plasma bij =
pati=EBnten=20
  ge=EFnfecteerd met HIV-1 lager zijn naarmate de ziekte verder is =
gevorderd. Een=20
  andere studie vond dat het gebrek aan lactoferrine (en secretoir IgA), =

  aangetroffen in de mondholten van mensen met HIV-1, sterk overeenkwam =
met de=20
  frequentie van infecties in dat gebied bij aids-pati=EBnten. =
</P></BLOCKQUOTE>
<DIV align=3Dleft>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%" border=3D0>
  <TBODY>
  <TR>
    <TD>
      <BLOCKQUOTE>
        <P class=3Dbody-tekst>Behalve studies waarbij naar voren kwam =
dat=20
        lactoferrine HIV en HCMV verhindert om gezonde cellen te =
infecteren,=20
        zijn er ook onderzoeken waarbij datzelfde mechanisme is ontdekt =
ten=20
        aanzien van herpes simplex type 1. Vermoedelijk wordt ook hier =
het=20
        hechten van het virus aan gezonde cellen steeds voorkomen door=20
        blokkering van de virale prote=EFnen, zowel als door directe =
maatregelen=20
        van het immuunsysteem via NK-cellen (natural killer cells), =
lymfocyten=20
        en fagocyten.</P></BLOCKQUOTE></TD>
    <TD width=3D400>
      <DIV align=3Dcenter>
      <TABLE cellPadding=3D10 width=3D300 bgColor=3D#f0fdea border=3D0>
        <TBODY>
        <TR>
          <TD>
            <P align=3Dcenter><B>Fatale cytomegalovirus-infecties in =
muizen konden=20
            worden tegengehouden doordat lactoferrine de daadkracht van =
de=20
            lymfocyten (natural killer cells) in het doden en verwoesten =
van=20
            virussen vergroot. De muizen die in dit experiment geen =
lactoferrine=20
            kregen toegediend, overleefden geen van=20
      =
allen.</B></P></TD></TR></TBODY></TABLE></DIV></TD></TR></TBODY></TABLE><=
/DIV>
<BLOCKQUOTE>
  <P class=3Dbody-tekst align=3Dleft>In een experiment waarin muizen =
werden besmet=20
  met een virus dat op leukemie gelijkende symptomen veroorzaakt, bleek =
de groep=20
  die daarbij lactoferrine kreeg toegediend de ziekteverschijnselen =
aanzienlijk=20
  beter te verdragen dan de groep die het zonder deze suppletie moest =
stellen.=20
  </P>
  <P class=3Dbody-tekst align=3Dleft>De onderzoekers Ikeda et al van het =
Japanse=20
  kankerinstituut rapporteren dat bovine lactoferrine effectief =
hepatitis C=20
  voorkwam in gekweekte levercellijnen door zich direct aan het =
hepatitis=20
  C-virus te binden en niet aan de ge=EFnfecteerde cellen.</P>
  <P class=3Dkopje align=3Dleft><BR>Microbi=EBle effecten</P>
  <DIV align=3Dleft>
  <P class=3Dbody-tekst>Bij de antibacteri=EBle effecten zijn zowel de=20
  ribonuclease-activiteit als de ijzerbindende kwaliteiten van =
lactoferrine=20
  betrokken. E=E9n manier waarop lactoferrine bacteri=EBn te lijf gaat, =
is dat het=20
  ene deel van het lactoferrinemolecuul zich aan de bacterie hecht, =
terwijl een=20
  ander deel 'ijzerkogels' op het membraan ervan afvuurt. Hierdoor valt =
de=20
  bacterie uiteen en wordt deze vervolgens door zijn eigen enzymen =
vernietigd.=20
  Een pregnant voorbeeld van biologische oorlogvoering.</P></DIV>
  <DIV align=3Dleft>
  <P class=3Dbody-tekst>Veel pathogene bacteri=EBn - en ook andere =
microben - zijn=20
  voor hun groei en vermenigvuldiging van ijzer afhankelijk. =
Lactoferrine weet=20
  dit voor hen essenti=EBle element consequent buiten bereik te houden. =
Vooral=20
  Stafylococcus aureus, Escherichia coli, Klebsiella pneumoni=E6 en =
Heliobacter=20
  pylori (de belangrijkste microbi=EBle veroorzaker van maagzweren) zijn =
niet=20
  bestand tegen de barri=E8res die lactoferrine voor hen opwerpt. Zo =
bevestigde=20
  zowel in vitro-, als in vivo-onderzoek inhibitie door lactoferrine van =
de=20
  toxische Heliobacter pylori. De lactoferrine, toegevoegd aan het =
drinkwater=20
  van muizen die met stafylokokken waren ge=EFnfecteerd, reduceerde hun=20
  nierontstekingen met 40-60%, terwijl het getelde aantal bacteri=EBn =
vijf- tot=20
  twaalfmaal minder bedroeg dan in de controlegroep.</P></DIV>
  <DIV align=3Dleft>
  <P class=3Dbody-tekst>Zoals gezegd komt lactoferrine voor in diverse=20
  klierafscheidingen. Zo fungeert deze stof samen met de in het speeksel =

  aanwezige antimicrobi=EBle enzymen lysozym en peroxidase als =
bescherming tegen=20
  gaatjes in het tandglazuur. Ook bepaalde schimmels, waaronder candida=20
  albicans, worden door lactoferrine in hun activiteiten =
gehinderd.</P></DIV>
  <DIV align=3Dleft>
  <P class=3Dbody-tekst>Parasieten worden door lactoferrine aangepakt =
via=20
  fagocytose, een proces waarbij immuuncellen vreemde organismen eerst=20
  overmeesteren en deze daarna verteren.</P></DIV>
  <P class=3Dkopje align=3Dleft><BR>Immuunondersteunende effecten</P>
  <P class=3Dbody-tekst align=3Dleft>Onderzoek wijst uit dat =
lactoferrine de=20
  proliferatie, rijping en activering van verscheidene soorten =
immuuncellen=20
  reguleert, bijvoorbeeld de neutrofielen en macrofagen, immuuncellen=20
  verantwoordelijk voor fagocytose. Neutrofielen, de leukocyten die zich =
in het=20
  begin van een ontstekingsreactie aan de vaatwand hechten, scheiden =
gedurende=20
  de loop van die ontsteking lactoferrine uit. Daarnaast be=EFnvloedt =
lactoferrine=20
  de rijping en functie van lymfocyten, immuuncellen verantwoordelijk =
voor de=20
  afscheiding van antilichamen en cellen die de vreemde organismen =
rechtstreeks=20
  te lijf gaan. Fatale cytomegalovirus-infecties in muizen konden worden =

  tegengehouden doordat lactoferrine de daadkracht van de lymfocyten =
(natural=20
  killer cells) in het doden en verwoesten van virussen vergroot. De =
muizen die=20
  in dit experiment geen lactoferrine kregen toegediend, overleefden =
geen van=20
  allen.</P></BLOCKQUOTE>
<BLOCKQUOTE>
  <P class=3Dbody-tekst align=3Dleft>Cytokinen zijn biochemische =
mediatoren die het=20
  immuunsysteem aansturen via specifieke interacties tussen de =
verschillende=20
  klassen immuuncellen. De cytokinen die de interacties reguleren tussen =
witte=20
  bloedcellen, oftewel leukocyten, heten interleukinen. Hedendaags =
onderzoek=20
  richt zich onder meer specifiek op het vermogen van lactoferrine om de =

  activiteit en het vrijmaken van interleukinen en andere cytokinen te=20
  reguleren.</P>
  <P class=3Dkopje align=3Dleft><BR>Spijsverteringskanaal</P>
  <P class=3Dbody-tekst align=3Dleft>Het maagdarmkanaal kan worden =
gezien als een=20
  ecologisch systeem waarin voor de optimale opname van voedingsstoffen =
een=20
  bepaalde balans moet heersen tussen de verschillende daarin aanwezige =
'goede'=20
  en 'kwade' bacteri=EBn. Als in dat systeem de verkeerde bacteri=EBn de =
overhand=20
  krijgen levert dat een reeks aan problemen op, die op hun beurt vrij =
baan=20
  geven aan talloze pro-inflammatoire mediatoren. </P></BLOCKQUOTE>
<DIV align=3Dleft>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"96%" border=3D0>
  <TBODY>
  <TR>
    <TD>
      <P align=3Dcenter><IMG height=3D331 hspace=3D39=20
      =
src=3D"file:///D:/Alternatieve%20geneeskunde%202005/Alternatieve%20genees=
kunde/Amino's/LACTOFERRINE%20-%20Fascinerende%20bondgenoot%20in%20de%20ve=
rdediging%20tegen%20endogene%20en%20exogene%20belagers_bestanden/lactofer=
rine.jpg"=20
      width=3D495 border=3D0><BR><B><FONT face=3DArial =
size=3D2><STRONG>Grafische=20
      weergave lactoferrine.</STRONG><STRONG style=3D"FONT-WEIGHT: =
400"><BR>Bron:=20
      Laboratory of Structural Biology, <BR>The University of Auckland, =
New=20
      Zealand</STRONG></FONT></B></P></TD>
    <TD>
      <P class=3Dbody-tekst>Het eindresultaat van deze cascade is dat er =
door het=20
      gehele darmsysteem heen verstoringen optreden. Zoals altijd is het =
ook=20
      hierbij belangrijk om de mens als geheel te beschouwen en bij de =
mond te=20
      beginnen, want ook daar zal het ecologisch evenwicht tussen de 200 =
- 300=20
      daar voorkomende (overwegend vriendelijke) bacteri=EBn in orde =
moeten zijn.=20
      Suikers uit voeding kunnen de verkeerde mondbacteri=EBn tot groei =
aanzetten,=20
      waardoor cari=EBs kan ontstaan. Dit kan vervolgens de mond tot een =

      infectueuze haard maken die ten slotte een bedreiging voor het =
gehele=20
      lichaam vormt. Zo zijn er verbanden gevonden tussen ontstekingen =
in de=20
      mond en hart-, en vaatziekten, en ook vroeggeboorten. Wat het =
verband=20
      betreft tussen de staat van de mond en het gebit, en de organen in =
de rest=20
      van het lichaam, loopt Nederland aanzienlijk achter bij landen als =
Zweden=20
      en Zwitserland. Hier onderschat men nog altijd de cruciale functie =
die de=20
      epitheliale contactvlakken van mond en keel hebben als =
verdedigingszones=20
      tegen infecties.</P></TD></TR></TBODY></TABLE></DIV>
<BLOCKQUOTE>
  <P class=3Dbody-tekst align=3Dleft>Lactoferrine heeft laten zien de =
goede=20
  bacteri=EBn in de darm dramatisch in aantal te kunnen doen toenemen, =
terwijl het=20
  tegelijkertijd de slechte doet afnemen. Vooral E. coli, Stafylococcus, =

  Streptococcus, Klebsiella pneumoni=E6, Heliobacter pylori en =
Clostridium blijken=20
  zeer gevoelig voor de krachtige wijze waarop lactoferrine het voor hen =
zo=20
  essenti=EBle ijzer buiten bereik houdt. De 'goede' darmbacteri=EBn, =
zoals=20
  lactobacillus acidofilus, lactobacillus bifidus en lactobacillus GG =
zijn voor=20
  hun ijzerbehoefte vermoedelijk minder afhankelijk van exogene bronnen =
en=20
  hebben daarom minder last van deze eigenschap van lactoferrine. </P>
  <P class=3Dkopje align=3Dleft><BR>Voorkomen =E9n genezen</P>
  <P class=3Dbody-tekst align=3Dleft>Naast de eigenschap infecties te =
voorkomen, kan=20
  lactoferrine deze ook helpen te genezen. Uit dieronderzoek is gebleken =
dat de=20
  stof in staat is zowel intestinale als systemische ontstekingen =
aanzienlijk te=20
  doen verminderen; niet alleen bij specifieke infecties, maar ook bij =
meer=20
  chronische aandoeningen. Bij proefdieren die pathogenen kregen =
toegediend=20
  zodat bij hen zowel intestinale als systemische darminfecties =
ontstonden,=20
  blijkt suppletie met lactoferrine niet alleen de beschadigingen aan de =

  darmwand maar ook de infecties terug te dringen.</P></BLOCKQUOTE>
<DIV align=3Dleft>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%" border=3D0>
  <TBODY>
  <TR>
    <TD>
      <BLOCKQUOTE>
        <P class=3Dbody-tekst>Indien het epitheel van de darm beschadigd =
is=20
        (lekkende darm syndroom) dan kunnen behalve grotere =
eiwitmoleculen ook=20
        bacteri=EBn rechtstreeks van de darm het bloed en het lymfatisch =
systeem=20
        binnenkomen. Bij dat laatste spreekt men van bacteri=EBle =
translocatie.=20
        Ongewenst migrerende eiwitten kunnen leiden tot verstoringen op=20
        geestelijk niveau en indien wat betreft de bacteri=EBn het =
immuunsysteem=20
        niet tussenbeide komt kunnen hieruit infecties en ziekten=20
      ontstaan.</P></BLOCKQUOTE></TD>
    <TD width=3D400>
      <DIV align=3Dcenter>
      <TABLE cellPadding=3D10 width=3D300 bgColor=3D#d2ebf2 border=3D0>
        <TBODY>
        <TR>
          <TD>
            <P align=3Dcenter><B>Lactoferrine speelt niet alleen een =
systemische=20
            rol in de verbetering van de effectiviteit van immuuncellen =
op=20
            kankercellen, maar blijkt daarop ook een direct effect te =
hebben, al=20
            is nog niet geheel duidelijk op basis van precies welke =
mechanismen=20
            dit=20
gebeurt.</B></P></TD></TR></TBODY></TABLE></DIV></TD></TR></TBODY></TABLE=
></DIV>
<BLOCKQUOTE>
  <P class=3Dbody-tekst align=3Dleft>Naast het vermogen om de =
bacteriegroei in goede=20
  banen te leiden, blijkt lactoferrine in staat dit proces te keren door =
de=20
  intestinale celgroei aanzienlijk te bevorderen. De stof is daarmee =
niet alleen=20
  een immuunmodulator, maar ook een zeer krachtig probioticum.</P>
  <P class=3Dbody-tekst align=3Dleft>In een onderzoek met muizen werd =
door suppletie=20
  met lactoferrine het dodelijk effect van het endotoxine =
lipopolysaccharide=20
  dramatisch teruggedrongen, terwijl de immuunrespons van deze dieren=20
  aanzienlijk toenam. Lipopolysaccharide kan ernstige toxische shock =
opleveren=20
  en voor intensive care-pati=EBnten in ziekenhuizen betekent deze =
gifstof een=20
  belangrijke doodsoorzaak.</P>
  <P class=3Dbody-tekst align=3Dleft>Het bij biggen inspuiten van het =
endotoxine=20
  Escherichia coli resulteerde in de groep die tijdens deze studie =
lactoferrine=20
  kreeg toegediend tot 17% sterfgevallen, in de groep zonder deze =
ondersteuning=20
  bedroeg dat percentage 74.</P>
  <P class=3Dkopje align=3Dleft><BR>Anti-oxidant kwaliteiten</P>
  <P class=3Dbody-tekst align=3Dleft>Afhankelijk van (de vraag vanuit) =
de cellulaire=20
  omgeving is lactoferrine een anti-oxidant die in staat is om vrij =
ijzer op te=20
  vangen - en daarmee ongecontroleerde, op ijzer gebaseerde vrije =
radicalen=20
  reacties te helpen voorkomen - of fungeert de stof als donor die ijzer =
kan=20
  afgeven wanneer het lichaam daar om vraagt. Ziekten als kanker, =
hartziekten en=20
  aids zijn allemaal nauw gerelateerd aan oxidatieve stress, hetzij als=20
  oorzakelijk gegeven, hetzij als bezwarende factor gedurende de =
progressie van=20
  de ziekte. Verscheidene studies suggereren dat lactoferrine het =
vermogen heeft=20
  om oxidatieve stress te verminderen. Een studie die de rol onderzocht =
van=20
  weiprote=EFnen, multigefermenteerde weiprote=EFnen en lactoferrine, =
leidde tot de=20
  uitspraak dat "deze stoffen goede kandidaten zijn om als inhiberende=20
  dieetmaatregel te worden ingezet ter voorkoming van oxidatieve stress, =
en=20
  zouden kunnen worden beschouwd als potenti=EBle medicinale =
voedingsstoffen voor=20
  verschillende pathologie=EBn, zoals HIV-infecties en kanker".</P>
  <P class=3Dkopje align=3Dleft><BR>Kanker</P>
  <P class=3Dbody-tekst align=3Dleft>Terwijl het aan steeds meer mensen =
duidelijk=20
  wordt dat kanker, naast vanuit omgevingsfactoren, zeker ook vanuit =
psychische=20
  en emotionele achtergronden kan ontstaan, blijkt lactoferrine een =
machtige=20
  bondgenoot op de weg naar fysiek herstel daarvan. </P><FONT=20
face=3DArial></BLOCKQUOTE>
<DIV align=3Dleft>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"96%" border=3D0>
  <TBODY>
  <TR>
    <TD>
      <P align=3Dcenter><IMG height=3D317 hspace=3D39=20
      =
src=3D"file:///D:/Alternatieve%20geneeskunde%202005/Alternatieve%20genees=
kunde/Amino's/LACTOFERRINE%20-%20Fascinerende%20bondgenoot%20in%20de%20ve=
rdediging%20tegen%20endogene%20en%20exogene%20belagers_bestanden/koeien.j=
pg"=20
      width=3D420 border=3D0><BR><FONT face=3DArial><B><FONT =
size=3D2><STRONG>Het=20
      peptide lactoferrine wordt ge=EFsoleerd uit<BR>wei van koeienmelk. =
De=20
      hiervoor benodigde<BR>filtertechnieken zijn recentelijk ontwikkeld =

      in<BR>Nieuw-Zeeland en Nederland.</STRONG></FONT></B><FONT=20
      size=3D2><B><STRONG style=3D"FONT-WEIGHT: 400">=20
      Archieffoto</STRONG></B></FONT></FONT></P></TD>
    <TD>
      <P class=3Dbody-tekst>Gezien de verbazingwekkende effecten die =
deze=20
      non-toxische stof op kanker heeft, lijkt de relatief recentelijke=20
      beschikbaarheid de enige reden waarom deze substantie nog niet =
standaard=20
      in kankerbehandelingen is opgenomen. Behalve dat lactoferrine de=20
      angiogenese onderdrukt -&nbsp; de aanmaak van nieuwe bloedvaten,=20
      onontbeerlijk voor het bloeddorstig (voort)bestaan van =
kankercellen -=20
      blijkt deze stof in onderzoeken met muizen ook lever- en =
longmetastasen=20
      aanzienlijk te beperken.</P>
      <P class=3Dbody-tekst>&nbsp;Dierstudies laten verder zien dat =
lactoferrine=20
      in verschillende kankercellijnen al bij lage concentraties een =
hoge=20
      NK-celtoxiciteit oplevert. Lactoferrine speelt niet alleen een =
systemische=20
      rol in de verbetering van de effectiviteit van immuuncellen op=20
      kankercellen, maar blijkt daarop ook een direct effect te hebben, =
al is=20
      nog niet geheel duidelijk op basis van precies welke mechanismen =
dit=20
      gebeurt. Ook de onderzoekers die vaststelden in welke aanzienlijke =
mate=20
      lactoferrine de groei van pancreaskankercellen blijkt te kunnen=20
      onderdrukken, kwamen tot de conclusie dat dit melkeiwit wel eens =
een van=20
      de meest gewilde stoffen zou kunnen worden als ondersteunend =
middel in de=20
      therapie tegen =
pancreaskanker.</P></TD></TR></TBODY></TABLE></DIV></FONT>
<BLOCKQUOTE><FONT face=3DArial></FONT>
  <P class=3Dbody-tekst align=3Dleft>Opvallend is dat terwijl koemelk in =
Japan pas=20
  in 1945 als voedingsstof werd ge=EFntroduceerd door de Amerikanen, =
veel van het=20
  onderzoek naar de effecten van de daaruit afkomstige lactoferrine door =

  Japanners is uitgevoerd en gepubliceerd. Zo voerde het nationale =
kanker=20
  researchcentrum in Tokio een onderzoek uit waarbij lactoferrine =
colonkanker=20
  bij ratten met de helft deed verminderen.</P>
  <P class=3Dkopje align=3Dleft><BR>Tot slot</P>
  <P class=3Dbody-tekst align=3Dleft>Behalve als voedingssupplement =
heeft=20
  lactoferrine inmiddels ook andere commerci=EBle toepassingen gekregen, =
zoals het=20
  langer houdbaar maken van levensmiddelen - de stof beschermt vlees =
tegen meer=20
  dan dertig bacteri=EBn, waaronder E. coli, salmonella en =
campylobacter. Verder=20
  wordt lactoferrine toegepast bij het kweken van vis, als toevoeging in =

  babyvoeding en in producten voor mondhygi=EBne.</P>
  <P class=3Dbody-tekst align=3Dleft>Vele van de positieve kwaliteiten =
van=20
  lactoferrine, voortkomend vanuit anekdotisch bewijs, worden inmiddels =
door=20
  onderzoeksresultaten gesteund. En ook al zal er nog meer onderzoek =
moeten=20
  plaatsvinden eer de gemiddelde wetenschapper zich durft te laten =
overtuigen,=20
  lactoferrine verdient nu al een prominente plaats in het bewustzijn =
van zowel=20
  artsen, oncologen en therapeuten, als van pati=EBnten.</P>
  <P class=3Dkopje align=3Dleft><BR>Geraadpleegde literatuur</P><FONT =
face=3DArial>
  <P class=3Dreferenties align=3Dleft>- <I>'The Townsend Letter for =
Doctors and=20
  Patients'</I>; www.townsendletter.com/.</P>
  <P class=3Dreferenties align=3Dleft>- Lonnerdal B: <I>'Nutritional and =
physiologic=20
  significance of human milk proteins'</I>; Am. J. Clin. Nutr.=20
  77(6):1537S-1543S, 2003.</P>
  <P class=3Dreferenties align=3Dleft>- Baveye S, Elass E, Mazurier J, =
Spik G,=20
  Legrand D: <I>'Lactoferrin: a multifunctional glycoprotein involved in =
the=20
  modulation of the inflammatory process'</I>; Clin. Chem. Lab. Med.=20
  37(3):281<FONT face=3D"WP TypographicSymbols">B</FONT>286, 1999.</P>
  <P class=3Dreferenties align=3Dleft>- Dial EJ, Hall LR, Serna H, =
Romero JJ, Fox=20
  JG, Lichtenberger LM: <I>'Antiobiotic properties of bovine lactoferrin =
on=20
  Heliobacter pylori'</I>; Dig. Dis. Sci. 43(12):2750<FONT=20
  face=3D"WP TypographicSymbols">B</FONT>2756, 1998.</P>
  <P class=3Dreferenties align=3Dleft>- Zhang GH, Mann DM, Tsai CM:=20
  <I>'Neutralization of endotoxin in vitro and in vivo by a human=20
  lactoferrin-derived peptide'</I>; Infect. Immun. 67(3):1353<FONT=20
  face=3D"WP TypographicSymbols">B</FONT>1358, 1999.</P>
  <P class=3Dreferenties align=3Dleft>- Lee WJ, Farmer JL, Hilty M, Kim =
YB: 'The=20
  protective effects of lactoferrin feeding against toxic shock in =
germfree=20
  piglets'; Infect. Immun. (66)4:1421<FONT=20
  face=3D"WP TypographicSymbols">B</FONT>1426, 1999.</P>
  <P class=3Dreferenties align=3Dleft>- Yoo YC, Watanabe S, Watanae R, =
Hata K,=20
  Shimazaki K, Azuma I: <I>'Bovine lactoferrine and lactoferricin, a =
peptide=20
  derived from bovine lactoferrine, inhibit tumor metastasis in =
mice'</I>; Jpn.=20
  J. Cancer Res. 88(20):184<FONT face=3D"WP =
TypographicSymbols">B</FONT>190,=20
  1997.</P>
  <P class=3Dreferenties align=3Dleft>- Defer MC, Dugas B, Picard O, =
Damais C:=20
  <I>'Impairment of circulating lactoferrine in HIV-1 infection'</I>; =
Cell Mol.=20
  Biol. (Noisy-le-Grand) 41(3):417<FONT=20
  face=3D"WP TypographicSymbols">B</FONT>421, 1995.</P>
  <P class=3Dreferenties align=3Dleft>- Muller F, Holberg-Petersen M, =
Rolag H, Degre=20
  M, Brandtzaeg P, Froland SS: <I>'Nonspecific oral immunity in =
individuals with=20
  HIV infection'</I>; J. Acquir. Immune Defic. Syndr. 5(1):46-51, =
1992.</P>
  <P class=3Dreferenties align=3Dleft>- Florisa R, Recio I, Berkhout B, =
Visser S:=20
  <I>'Antibacterial and antiviral effects of milk proteins and derivates =

  thereof'</I>; Curr. Pharm. Des. 9(16):1257<FONT=20
  face=3D"WP TypographicSymbols">B</FONT>1275, 2003.</P>
  <P class=3Dreferenties align=3Dleft>- Clare DA, Catignani GL, =
Swaisgood HE:=20
  <I>'Biodefense properties of milk: the role of antimicrobial proteins =
and=20
  peptides'</I>; Curr. Pharm. Des. 9(16):1239<FONT=20
  face=3D"WP TypographicSymbols">B</FONT>1255, 2003.</P>
  <P class=3Dreferenties align=3Dleft>- Swart PJ, Kuipers EM, Smit C, =
van der Strate=20
  BW, Harmsen MC, Meijer DK: <I>'Lactoferrin. Antiviral activity of=20
  lactoferrin'</I>; Adv. Exp. Med. Biol. 443:205<FONT=20
  face=3D"WP TypographicSymbols">B</FONT>213, 1998.</P>
  <P class=3Dreferenties align=3Dleft>- Moshynskyy I, Jiang M, Fontaine =
MC,=20
  Perez-Casal J, Babiuk LA: <I>'Characterization of a bovine =
lactoferrine=20
  binding protein of Streptococcus uberis'</I>; Microb. Path =
35(5):203<FONT=20
  face=3D"WP TypographicSymbols">B</FONT>215, 2003.</P>
  <P class=3Dreferenties align=3Dleft>- Sakamoto N: <I>'Antitumor effect =
of human=20
  lactoferrine against newly established human pancreatic cancer cell =
line=20
  SPA'</I>; Gan To Kagaku Ryoho 25(10):63, 1998.</P>
  <P class=3Dreferenties align=3Dleft>- R=F6ver DL: <I>'Kiezen of =
helen'</I>; Arts=20
  &amp; Apotheker.</P>
  <P class=3Dreferenties align=3Dleft>- Jianglin He, Philip Furmanski: =
<I>'Sequence=20
  specificity and transcriptional activation in the binding of =
lactoferrin to=20
  DNA'</I>; (Letters to Editor) Nature 373:721<FONT=20
  face=3D"WP TypographicSymbols">B</FONT>724, 1995.</P>
  <P class=3Dreferenties align=3Dleft>- Singh PK, Parsek MR, Greenberg=20
  EP,&nbsp;Welsh MJ: <I>'A component of innate immunity prevents =
bacterial=20
  biofilm development'</I>; Nature 417:552<FONT=20
  face=3D"WP TypographicSymbols">B</FONT>555, 2002.</P>
  <P class=3Dreferenties align=3Dleft>- Weinberg ED: <I>'The therapeutic =
potential=20
  of lactoferrin'</I>; Expert Opin. Investig. Drugs 12(5):841<FONT=20
  face=3D"WP TypographicSymbols">B</FONT>851, =
2003.</P></FONT></BLOCKQUOTE>
<CENTER>
<TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"98%" bgColor=3D#f2a228 =
border=3D0>
  <TBODY>
  <TR>
    <TD align=3Dmiddle width=3D"100%">
      <P align=3Dleft><IMG height=3D1 src=3D""=20
width=3D10></P></TD></TR></TBODY></TABLE></CENTER></DIV>
<DIV align=3Dcenter>
<CENTER>
<P><FONT face=3D"Times New Roman"><IFRAME name=3DI2 marginWidth=3D0 =
marginHeight=3D0=20
src=3D"file://D:\Alternatieve geneeskunde 2005\Alternatieve =
geneeskunde\Amino's\LACTOFERRINE - Fascinerende bondgenoot in de =
verdediging tegen endogene en exogene belagers_bestanden\insert_adr.htm" =

frameBorder=3D0 width=3D300 scrolling=3Dno=20
height=3D105>
</IFRAME></FONT></P></CENTER></DIV>
<P align=3Dcenter><FONT face=3D"Times New Roman"><FONT =
size=3D2><B>Copyright =A9 2004=20
Orthos Media bv</B></FONT><BR><BR>&nbsp;</FONT></P></BODY></HTML>

------=_NextPart_001_000B_01C6EB8C.8D0DF9D0
Content-Type: text/html;
	charset="Windows-1252"
Content-Transfer-Encoding: quoted-printable
Content-Location: file://D:\Alternatieve geneeskunde 2005\Alternatieve geneeskunde\Amino's\LACTOFERRINE - Fascinerende bondgenoot in de verdediging tegen endogene en exogene belagers_bestanden\adresregel-insert.htm

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from =
url=3D(0052)http://www.orthos.nl/media/div/adresregel-insert.htm =
--><HTML><HEAD><TITLE></TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dwindows-1252">
<META content=3D"Stichting Orthomoleculaire Educatie, Den Haag, The =
Netherlands"=20
name=3DAuthor>
<META content=3D"Stichting Orthomoleculaire Educatie, Den Haag, The =
Netherlands"=20
name=3DCopyright>
<META content=3D"MSHTML 6.00.5700.6" name=3DGENERATOR>
<META content=3DFrontPage.Editor.Document name=3DProgId>
<META content=3Dnoindex name=3Drobots></HEAD>
<BODY bgColor=3D#ffffff topMargin=3D0>
<P align=3Dcenter><FONT face=3DArial size=3D1>Uitgeverij Orthos Media =
bv&nbsp; |&nbsp;=20
Postbus 84041&nbsp; |&nbsp; 2508 AA Den Haag&nbsp; |&nbsp; Telefoon=20
070-3585673&nbsp; |&nbsp; Fax 070-3587504</FONT></P></BODY></HTML>

------=_NextPart_001_000B_01C6EB8C.8D0DF9D0--

------=_NextPart_000_0000_01C6EB8C.8D0B88D0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: file:///D:/Alternatieve%20geneeskunde%202005/Alternatieve%20geneeskunde/Amino's/LACTOFERRINE%20-%20Fascinerende%20bondgenoot%20in%20de%20verdediging%20tegen%20endogene%20en%20exogene%20belagers_bestanden/insert_adr_bestanden/back.gif
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------=_NextPart_000_0000_01C6EB8C.8D0B88D0
Content-Type: text/html;
	charset="Windows-1252"
Content-Transfer-Encoding: quoted-printable
Content-Location: file://D:\Alternatieve geneeskunde 2005\Alternatieve geneeskunde\Amino's\LACTOFERRINE - Fascinerende bondgenoot in de verdediging tegen endogene en exogene belagers_bestanden\insert_adr.htm

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from =
url=3D(0045)http://www.orthos.nl/media/div/insert_adr.htm =
--><HTML><HEAD><TITLE></TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dwindows-1252">
<META content=3D"Orthos Media bv, Den Haag, Netherlands" name=3DAuthor>
<META content=3D"Orthos Media bv, Den Haag, Netherlands" =
name=3DCopyright>
<META content=3D"MSHTML 6.00.5700.6" name=3DGENERATOR>
<META content=3DFrontPage.Editor.Document name=3DProgId>
<META content=3Dnoindex name=3Drobots></HEAD>
<BODY=20
background=3D"file:///D:/Alternatieve%20geneeskunde%202005/Alternatieve%2=
0geneeskunde/Amino's/LACTOFERRINE%20-%20Fascinerende%20bondgenoot%20in%20=
de%20verdediging%20tegen%20endogene%20en%20exogene%20belagers_bestanden/i=
nsert_adr_bestanden/back.gif">
<P align=3Dcenter><FONT face=3D"Times New Roman">&nbsp;<I>Uitgeverij =
Orthos Media=20
bv<BR>Postbus 84041<BR>2508 AA Den Haag<BR>Telefoon 070-3585673<BR>Fax=20
070-3587504</I> </FONT></P></BODY></HTML>

------=_NextPart_000_0000_01C6EB8C.8D0B88D0--

